Global platelet and plasma market size is anticipated to reach the market value of around USD 8.1 Billion by 2028 and is anticipated to grow at a CAGR of around 3.4% in terms of revenue during the forecast period 2021 - 2028.
Platelet and Plasma Market Insights
The increased incidence of a number of chronic diseases, for which care includes blood and transfusion of blood components or surgery, are two of the main reasons expected to move against the market. One significant factor of the increasing market for plasma is the substantial increase in the prevalence of many neurological disorders. The demand will also be driven by a significant growth in voluntary blood donations worldwide, a major role played by governments and non-profit organizations in fostering the need for the same and the investment to improve the blood storage capacity in developing economies. Throughout the near term, increasing appetite for the innovative diagnosis of a variety of disorders, expanded spending from leading players into R&D for chronic disease therapies, and increased support for successful treatments of genetic diseases are likely to be major advantages for the increasing. However, owing to the lack of adequate storage facilities in several low-income countries, the tight plasma collecting legislation and low-accessibility technologies and equipment for the isolation of blood components in many countries around the globe, the demand could be hampered.
Hospitals segment will garner a significant share over the forecast timeframe
In 2020, hospitals accounted for some 62% of the market and are expected to rise steadily over the next few years. The growth in this group is due to increased blood supply in hospitals, such as platelet and plasma, which increases segmental development and the rise in the number in operations involving blood transfusion. Such operations are typically carried out in hospital settings, which allow the section to expand. Furthermore, a increasing number of well-established hospitals and expanded healthcare availability have a positive effect on business growth.
The North America plasma and platelets market is expected in 2020 to be strongly included in the study and over 1.5% CAGR. Regional development is largely due to favorable laws surrounding the use of platelets and related plasma materials. In addition, the elevated demand for platlets and plasma is growing, and the global business development is booming, with the rising number of patients with obesity, cancer, cardiothoracic diseases, as well as growing incidences of neurological disorders. However, the development of regional demand growth will be further enhanced by increasing health spending and many acts by organizations including setting-up blood donation campaigns. Growing demand for European blood transfusion processes would fuel business growth during the projected period. The rise in demand for platelet and plasma that drives business development in European countries has seen an increasing number of blood banks in recent years. Across these nations, blood transfusion is also a complex form of healthcare. Of example, more than 60 blood banks currently supply all blood components, including platelets and plasma in Norway's hospitals. Most licensed and qualified blood banks donate blood. The demand growth will be driven by the projected timetable. More than 115 million units of donated blood is collected globally annually, as well as approximately 42 per cent in high-income countries in the Americas and Europe, according to the World Health Organization (WHO). Increasing numbers of blood donor camps would raise patient demand dramatically over the expected period.
Platelet and Plasma Market Key Players
Major players included in this report are Spanish Red Cross, American Red Cross, America’s Blood Centers, Blood Centers of America, European Blood Alliance, Indian Red Cross Society, Japanese Red Cross Society, Red Cross Society of China, Saudi Red, Crescent Authority, Arthrex, Inc., South Africa Red Cross Society., AdiStem Ltd., and others. The players in the industry engage in numerous strategic contracts such as alliances and fusions to produce significant revenue shares in the plasma and plasma business. OneBlood merged in April 2020 with the Carolinas Inc 's Community Blood Center. The formula helped the corporation deliver over one million blood products in more than 250 hospitals throughout South Carolina, North Carolina, Alabama and Georgia.
The global platelet and plasma market is segmented as below:
Platelet and Plasma Market Segmentation
Platelet and Plasma Market By Component
Platelet and Plasma Market By Distribution Channel
- Hospitals
- Ambulatory surgical centers
- Others
Platelet and Plasma Market By Application
- Hemophilia
- Thrombocytopenia
- Perioperative indications
- Platelet function disorders
- Other platelet applications
- Coagulation factor deficiencies
- Thrombotic thrombocytopenic purpura
- Hemorrhage
- Liver disease
- Other plasma applications
Platelet and Plasma Market By Geography
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1.Industry Overview of Platelet and Plasma
1.1.Definition and Scope
1.1.1.Definition of Platelet and Plasma
1.1.2.Market Segmentation
1.1.3.Years Considered for the Study
1.1.4.Assumptions and Acronyms Used
1.1.4.1.Market Assumptions and Market Forecast
1.1.4.2.Acronyms Used in Global Platelet and Plasma Market
1.2.Summary
1.2.1.Executive Summary
1.2.2.Platelet and Plasma Market By Component
1.2.3.Platelet and Plasma Market By Distribution Channel
1.2.4.Platelet and Plasma Market By Application
1.2.5.Platelet and Plasma Market by Regions
CHAPTER 2.Research Approach
2.1.Methodology
2.1.1.Research Programs
2.1.2.Market Size Estimation
2.1.3.Market Breakdown and Data Triangulation
2.2.Data Source
2.2.1.Secondary Sources
2.2.2.Primary Sources
CHAPTER 3.Market Dynamics And Competition Analysis
3.1.Market Drivers
3.1.1.Driver 1
3.1.2.Driver 2
3.2.Restraints and Challenges
3.2.1.Restrain 1
3.2.2.Restrain 2
3.3.Growth Opportunities
3.3.1.Opportunity 1
3.3.2.Opportunity 2
3.4.Porter’s Five Forces Analysis
3.4.1.Bargaining Power of Suppliers
3.4.2.Bargaining Power of Buyers
3.4.3.Threat of Substitute
3.4.4.Threat of New Entrants
3.4.5.Degree of Competition
3.5.Market Concentration Ratio and Market Maturity Analysis of Platelet and Plasma Market
3.5.1.Go To Market Strategy
3.5.1.1.Introduction
3.5.1.2.Growth
3.5.1.3.Maturity
3.5.1.4.Saturation
3.5.1.5.Possible Development
3.6.Technological Roadmap for Platelet and Plasma Market
3.7.Value Chain Analysis
3.7.1.List of Key Manufacturers
3.7.2.List of Customers
3.7.3.Level of Integration
3.8.Cost Structure Analysis
3.8.1.Price Trend of Key Raw Materials
3.8.2.Raw Material Suppliers
3.8.3.Proportion of Manufacturing Cost Structure
3.8.3.1.Raw Material
3.8.3.2.Labor Cost
3.8.3.3.Manufacturing Expense
3.9.Regulatory Compliance
3.10.Competitive Landscape, 2020
3.10.1.Player Positioning Analysis
3.10.2.Key Strategies Adopted By Leading Players
CHAPTER 4.Manufacturing Plant Analysis
4.1.Manufacturing Plant Location and Establish Date of Major Manufacturers in 2020
4.2.R&D Status and Application Source of Platelet and Plasma Major Manufacturers in 2020
CHAPTER 5.Platelet and Plasma Market By Component
5.1.Introduction
5.2.Platelet and Plasma Revenue By Component
5.2.1.Platelet and Plasma Revenue (US$ Mn) and Forecast, By Component, 2017-2028
5.2.2.Platelets
5.2.2.1.Platelets Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3.Plasma
5.2.3.1.Plasma Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 6.Platelet and Plasma Market Revenue By Distribution Channel
6.1.Introduction
6.2.Platelet and Plasma Revenue (US$ Mn) By Distribution Channel
6.2.1.Platelet and Plasma Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
6.2.2.Hospitals
6.2.2.1.Hospitals Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.3.Ambulatory surgical centers
6.2.3.1.Ambulatory surgical centers Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.4.Others
6.2.4.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 7.Platelet and Plasma Market By Application
7.1.Introduction
7.2.Platelet and Plasma Revenue (US$ Mn) By Application
7.2.1.Platelet and Plasma Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
7.2.2.Hemophilia
7.2.2.1.Hemophilia Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.3.Thrombocytopenia
7.2.3.1.Thrombocytopenia Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.4.Perioperative indications
7.2.4.1.Perioperative indications Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.5.Platelet function disorders
7.2.5.1.Platelet function disorders Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.6.Other platelet applications
7.2.6.1.Other platelet applications Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.7.Coagulation factor deficiencies
7.2.7.1.Coagulation factor deficiencies Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.8.Thrombotic thrombocytopenic purpura
7.2.8.1.Thrombotic thrombocytopenic purpura Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.9.Hemorrhage
7.2.9.1.Hemorrhage Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.10.Liver disease
7.2.10.1.Liver disease Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.11.Other plasma applications
7.2.11.1.Other plasma applications Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 8.North America Platelet and Plasma Market By Country
8.1.North America Platelet and Plasma Overview
8.2.U.S.
8.2.1.U.S. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028
8.2.2.U.S. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
8.2.3.U.S. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
8.3.Canada
8.3.1.Canada Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028
8.3.2.Canada Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
8.3.3.Canada Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
8.4.North America PEST Analysis
CHAPTER 9.Europe Platelet and Plasma Market By Country
9.1.Europe Platelet and Plasma Market Overview
9.2.U.K.
9.2.1.U.K. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028
9.2.2.U.K. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
9.2.3.U.K. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.3.Germany
9.3.1.Germany Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028
9.3.2.Germany Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
9.3.3.Germany Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.4.France
9.4.1.France Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028
9.4.2.France Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
9.4.3.France Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.5.Spain
9.5.1.Spain Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028
9.5.2.Spain Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
9.5.3.Spain Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.6.Rest of Europe
9.6.1.Rest of Europe Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028
9.6.2.Rest of Europe Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
9.6.3.Rest of Europe Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.7.Europe PEST Analysis
CHAPTER 10.Asia Pacific Platelet and Plasma Market By Country
10.1.Asia Pacific Platelet and Plasma Market Overview
10.2.China
10.2.1.China Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
10.2.2.China Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
10.2.3.China Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.3.Japan
10.3.1.Japan Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
10.3.2.Japan Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
10.3.3.Japan Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.4.India
10.4.1.India Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
10.4.2.India Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
10.4.3.India Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.5.Australia
10.5.1.Australia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
10.5.2.Australia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
10.5.3.Australia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.6.South Korea
10.6.1.South Korea Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
10.6.2.South Korea Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
10.6.3.South Korea Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.7.Rest of Asia-Pacific
10.7.1.Rest of Asia-Pacific Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
10.7.2.Rest of Asia-Pacific Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
10.7.3.Rest of Asia-Pacific Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.8.Asia Pacific PEST Analysis
CHAPTER 11.Latin America Platelet and Plasma Market By Country
11.1.Latin America Platelet and Plasma Market Overview
11.2.Brazil
11.2.1.Brazil Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
11.2.2.Brazil Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
11.2.3.Brazil Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
11.3.Mexico
11.3.1.Mexico Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
11.3.2.Mexico Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
11.3.3.Mexico Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
11.4.Rest of Latin America
11.4.1.Rest of Latin America Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
11.4.2.Rest of Latin America Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.4.3.Rest of Latin America Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
CHAPTER 12.Middle East & Africa Platelet and Plasma Market By Country
12.1.Middle East & Africa Platelet and Plasma Market Overview
12.2.Saudi Arabia
12.2.1.Saudi Arabia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
12.2.2.Saudi Arabia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
12.2.3.Saudi Arabia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
12.3.UAE
12.3.1.UAE Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
12.3.2.UAE Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
12.3.3.UAE Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
12.4.Rest of Middle East & Africa
12.4.1.Rest of Middle East & Africa Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
12.4.2.Rest of Middle East & Africa Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
12.4.3.Rest of Middle East & Africa Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
CHAPTER 13.Player Analysis Of Platelet and Plasma
13.1.Platelet and Plasma Market Company Share Analysis
13.2.Competition Matrix
13.2.1.Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2.New Product Launches and Product Enhancements
13.2.3.Mergers And Acquisition In Global Platelet and Plasma Market
13.2.4.Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14.COMPANY PROFILE
14.1.Spanish Red Cross
14.1.1.Company Snapshot
14.1.2.Business Overview
14.1.3.Financial Overview
14.1.3.1.Revenue (US$ Mn), 2020
14.1.3.2.Spanish Red Cross 2020 Platelet and Plasma Business Regional Distribution
14.1.4.Product/ Service and Specification
14.1.5.Recent Developments & Business Strategy
14.1.6.Manufacturing Plant Footprint Analysis
14.2.American Red Cross
14.3.America’s Blood Centers
14.4.Blood Centers of America
14.5.European Blood Alliance
14.6.Indian Red Cross Society
14.7.Japanese Red Cross Society
14.8.Red Cross Society of China
14.9.Saudi Red
14.10.Crescent Authority
14.11.Arthrex, Inc.
14.12.South Africa Red Cross Society.
14.13.AdiStem Ltd.
14.14.Others
